Enrique Zudaire

Company: Caribou Biosciences

Job title: Senior Vice President - Translational Sciences & Therapeutics Discovery

Seminars:

Panel Discussion: Understanding the Merits & Feasibilities of HLA Matching 11:30 am

Explore the importance of HLA matching in improving patient outcomes and reducing the risk of allogeneic rejection in allogeneic therapies Evaluate the feasibility and logistical considerations of implementing HLA matching in clinical settings to optimize donor-recipient compatibility Discuss recent advancements and tools that facilitate HLA matching processes, enhancing the overall efficacy of allogeneic treatmentsRead more

day: Day Two - Track A AM

Maximizing Treatment Outcomes Through Strategic Patient Selection by HLA Matching 9:00 am

Explore the criteria for identifying patients who are most likely to benefit from allogeneic therapies, focusing on genetic, clinical, and demographic factors How can we determine which patient is more likely to have increased allogeneic rejection?Read more

day: Conference Day Two